Use of Stem Cell in Fetal Therapy: Current Status and Future Perspectives
Journal of the Korean Society of Maternal and Child Health
; : 92-99, 2017.
Artigo
em Coreano
| WPRIM (Pacífico Ocidental)
| ID: wpr-211730
Biblioteca responsável:
WPRO
ABSTRACT
During the past decades, there has been a great evolution in the field of fetal therapy for congenital defects. Prenatal screening or diagnostic methods including non-invasive and invasive methods and fetal ultrasound have led to earlier and more accurate diagnosis of congenital anomalies. Recent advances in several therapeutic techniques including ultrasound-guided needle therapy, laser therapy or fetal endoscopy, have allowed some fetuses at risk with anatomical defects, to be corrected in utero but still, its clinical indications remain limited. Over the last 30 years, many researchers found usefulness of pluripotent stem cells from amniotic fluid and placenta because they are sources of diverse progenitor cell populations called mesenchymal stem cells. In some human conditions like severe combined immunodeficiency syndrome and chronic granulomatous disease, fetal therapy using stem cell replacement showed some promising results in researches but more studies are required to apply in clinical settings. The aim of this article is to summarize a current status and future perspective of stem cell therapy for treatment of congenital fetal anomalies.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Placenta
/
Diagnóstico Pré-Natal
/
Células-Tronco
/
Anormalidades Congênitas
/
Ultrassonografia
/
Imunodeficiência Combinada Severa
/
Células-Tronco Pluripotentes
/
Terapias Fetais
/
Diagnóstico
/
Endoscopia
Tipo de estudo:
Estudo diagnóstico
Limite:
Feminino
/
Humanos
Idioma:
Coreano
Revista:
Journal of the Korean Society of Maternal and Child Health
Ano de publicação:
2017
Tipo de documento:
Artigo